STRUCTURED STREAM

 

At that stream, distinguished early career scientists and entrepreneurs are invited to work jointly on novel preclinical high impact projects within the areas of: Small Molecules,Orphan Drugs, Diagnostics and Future Health Technologies and Digital Health. The projects are proposed and co-jointly mentored by our industrial, academic and translational partners and they will form a core to what can become a future success story.

For industrial partners interested at co-jointly propose projects, please contact vinton.cheng@oxfordbiotech.org

 

 

Project types


Medicinal chemistry 

Partner: Structural Genomics Consortium (SGC) 

Your contribution: 

Could you chemically alter the probe to improve its binding specificity? Can you improve the pharmacokinetics to enhance drug delivery?


Novel Clinical Applications 

Partner: Structural Genomics Consortium (SGC)

Your contribution: 

Do you work in a disease area that is influenced by this protein family/target? Could you use the associated chemical probe to potentially develop into a new therapy for this disease?


Combination Therapy 

Partner: Structural Genomics Consortium (SGC)

Your contribution: 

Would combining certain chemical probes be more successful in combating a specific disease or a collection of diseases?


Assay Development 

Partner: Structural Genomics Consortium (SGC)

Your contribution: 

Can you create an assay or improve an existing assay to assess the function of the probe?